Ependymoma, Recurrent Recruiting Phase 2 Trials for Thalidomide (DB01041)

Also known as: Ependymoma Recurrent / Recurrent Ependymoma

IndicationStatusPhase
DBCOND0106575 (Ependymoma, Recurrent)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01356290Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRTTreatment